Schonfeld Strategic Advisors »

Gain Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 25k 1.94

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Kraneshares Trust Csi Chi Internet (KWEB)
CRH Ord (CRH)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Ishares Tr China Lg-cap Etf (FXI)
Palantir Technologies Cl A (PLTR)
Unity Software (U)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Schonfeld Strategic Advisors

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
Susquehanna International
Jones Financial Companies, L.L
Vanguard Group
Cambridge Investment Research Advisors
DME Capital Management
Geode Capital Management
Vanguard Capital Management
GSA Capital Partners
Jane Street
Vanguard Fiduciary Trust
BlackRock
UBS Group
Cresset Asset Management

View all funds holding Gain Therapeutics